JP6829620B2 - Solid bath salt - Google Patents
Solid bath salt Download PDFInfo
- Publication number
- JP6829620B2 JP6829620B2 JP2017028602A JP2017028602A JP6829620B2 JP 6829620 B2 JP6829620 B2 JP 6829620B2 JP 2017028602 A JP2017028602 A JP 2017028602A JP 2017028602 A JP2017028602 A JP 2017028602A JP 6829620 B2 JP6829620 B2 JP 6829620B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- component
- less
- acid
- points
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 title claims description 56
- 235000019341 magnesium sulphate Nutrition 0.000 title claims description 49
- 239000007787 solid Substances 0.000 title claims description 39
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 22
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 12
- 239000001530 fumaric acid Substances 0.000 claims description 11
- 150000007524 organic acids Chemical class 0.000 claims description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 6
- 235000011152 sodium sulphate Nutrition 0.000 claims description 6
- 229920003169 water-soluble polymer Polymers 0.000 claims description 5
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 239000013041 solid bath agent Substances 0.000 claims 1
- 238000003860 storage Methods 0.000 description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 18
- 206010016334 Feeling hot Diseases 0.000 description 18
- 230000007774 longterm Effects 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 13
- 239000001569 carbon dioxide Substances 0.000 description 9
- 229910002092 carbon dioxide Inorganic materials 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 238000005187 foaming Methods 0.000 description 9
- -1 Fatty acid esters Chemical class 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 8
- 238000003287 bathing Methods 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 238000004090 dissolution Methods 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- 239000004484 Briquette Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 2
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 2
- 229940075495 isopropyl palmitate Drugs 0.000 description 2
- 229940113915 isostearyl palmitate Drugs 0.000 description 2
- QIGOZTHDQZFDPY-UHFFFAOYSA-L magnesium;sulfate;trihydrate Chemical compound O.O.O.[Mg+2].[O-]S([O-])(=O)=O QIGOZTHDQZFDPY-UHFFFAOYSA-L 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229940078812 myristyl myristate Drugs 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229960002446 octanoic acid Drugs 0.000 description 2
- 229940073665 octyldodecyl myristate Drugs 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 239000010666 rose oil Substances 0.000 description 2
- 235000019719 rose oil Nutrition 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-YGPZHTELSA-N (5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene Chemical compound C1C2CC=C(C)[C@]1([H])C2(C)C GRWFGVWFFZKLTI-YGPZHTELSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- BODMYPYTCKYRSP-UHFFFAOYSA-N 1,1-dioctylcyclohexane Chemical compound CCCCCCCCC1(CCCCCCCC)CCCCC1 BODMYPYTCKYRSP-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000245214 Mentha canadensis Species 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 241000736892 Thujopsis dolabrata Species 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000010620 bay oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000000748 compression moulding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 description 1
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 235000013808 oxidized starch Nutrition 0.000 description 1
- 239000001254 oxidized starch Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000010665 pine oil Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Description
本発明は、固形入浴剤に関する。 The present invention relates to solid bath salts.
従来より、炭酸塩と有機酸を配合した入浴剤は、浴水中で炭酸ガスの泡を発生し、かかる炭酸ガスによって血行が促進されて温まり感が得られる等の効果が発揮されることから、優れた入浴剤として広く知られている。またこうした入浴剤に、さらに種々の成分を配合することで、付加的効果や相乗的効果をもたらす研究もなされている。 Conventionally, bath salts containing a carbonate and an organic acid generate carbon dioxide bubbles in the bath water, and the carbon dioxide gas promotes blood circulation and gives a feeling of warmth. Widely known as an excellent bath salt. Research has also been conducted to bring about additional effects and synergistic effects by further adding various components to such bath salts.
例えば、特許文献1には、有機酸としてリンゴ酸と特定量のフマル酸とを用いた固形浴用剤組成物が開示され、芒硝等の無機塩類も用い得る旨記載されており、優れた成形性やしっとりとした使用感を有し、浮遊物をなくして浴湯表面状態を良好にするものである。また、特許文献2には、クエン酸、フマル酸、酒石酸、アジピン酸等の有機酸と、炭酸塩と、硫酸ナトリウム、チオ硫酸ナトリウム、硫酸カリウム等の無機塩と、特定の結着剤と油剤とを含む粉末を加圧成形して得られた、特定の硬度を有する固体入浴剤が開示されており、使用時における素早い溶解性や高い発泡力を発揮し、使用感を高めている。 For example, Patent Document 1 discloses a solid bath composition using malic acid as an organic acid and a specific amount of fumaric acid, and describes that inorganic salts such as sardine can also be used, and has excellent moldability. It has a soft and moist feeling, eliminates floating substances, and improves the surface condition of the bath water. Further, Patent Document 2 describes organic acids such as citric acid, fumaric acid, tartaric acid and adipic acid, carbonates, inorganic salts such as sodium sulfate, sodium thiosulfate and potassium sulfate, and specific binders and oils. A solid bathing agent having a specific hardness, which is obtained by pressure-molding a powder containing and, is disclosed, and exhibits quick solubility and high foaming power at the time of use to enhance the feeling of use.
一方、こうした入浴剤において、温浴効果をさらに高めようとするにあたり、無機塩である硫酸マグネシウムが有用であることも知られており、その水和物が医薬部外品の有効成分として承認されている。 On the other hand, it is also known that magnesium sulfate, which is an inorganic salt, is useful in trying to further enhance the warm bath effect in such bath salts, and its hydrate has been approved as an active ingredient of quasi-drugs. There is.
しかしながら、硫酸マグネシウム水和物を固形入浴剤の一成分として用いると、含まれる水分子の存在によって成形性や保存安定性が低下するおそれが高まるところ、仮に上記特許文献に記載の技術において、かかる硫酸マグネシウム水和物を用いたとしても、製造時におけるスティッキング等の発生を防止するのが困難である上、長期保存後には浴水への充分な溶解性を示すことができず、依然として改善の余地がある。 However, when magnesium sulfate hydrate is used as one component of the solid bathing agent, the presence of water molecules contained in the magnesium sulfate hydrate increases the risk of deterioration in moldability and storage stability. Even if magnesium sulfate hydrate is used, it is difficult to prevent the occurrence of sticking during production, and after long-term storage, it cannot show sufficient solubility in bath water, and it is still improved. There is room.
すなわち、本発明は、硫酸マグネシウム水和物を用いて温まり感を有効に増強させつつ、良好な成形性を確保するとともに、長期保存後においても浴水への優れた溶解性を発現することのできる固形入浴剤に関する。 That is, in the present invention, magnesium sulfate hydrate is used to effectively enhance the feeling of warmth, ensure good moldability, and exhibit excellent solubility in bath water even after long-term storage. Regarding solid bath salts that can be made.
そこで本発明者は、種々検討したところ、炭酸塩と併用する有機酸として、敢えて有機酸のなかでも浴水への溶解性が低いとされるフマル酸を主たる成分として用いつつ、硫酸マグネシウム水和物と硫酸ナトリウムとを特定の合計含有量かつ特定の質量比で併用することにより、予想外にも硫酸マグネシウム水和物固有の問題を解決しながら、優れた効果を発揮することのできる固形入浴剤が得られることを見出した。 Therefore, as a result of various studies, the present inventor hydrated magnesium sulfate while using fumaric acid, which is said to have low solubility in bath water, as the main component of the organic acid to be used in combination with carbonate. By using a substance and sodium sulfate in combination at a specific total content and a specific mass ratio, a solid bath that can unexpectedly solve the problems peculiar to magnesium sulfate hydrate and exert excellent effects. It was found that the agent could be obtained.
したがって、本発明は、次の成分(A)、(B)、(C)、及び(D):
(A)フマル酸を35質量%以上含む有機酸、
(B)炭酸塩、
(C)硫酸マグネシウム水和物、及び
(D)硫酸ナトリウム
を含有し、成分(C)と成分(D)の合計含有量が0.1質量%以上25質量%以下であり、かつ成分(C)の含有量と成分(D)の含有量との質量比((C)/(D))が0.28以上2.0以下である固形入浴剤を提供する。
Therefore, the present invention describes the following components (A), (B), (C), and (D):
(A) An organic acid containing 35% by mass or more of fumaric acid,
(B) Carbonate,
It contains (C) magnesium sulfate hydrate and (D) sodium sulfate, and the total content of the component (C) and the component (D) is 0.1% by mass or more and 25% by mass or less, and the component (C). ) To the mass ratio ((C) / (D)) of the content of the component (D) is 0.28 or more and 2.0 or less.
本発明の固形入浴剤によれば、硫酸マグネシウム水和物を一成分として用いながらも、スティッキング等の発生を防止して良好な成形性を確保するとともに、長期保存後においても浴水への優れた溶解性を発現することができる上、さらに血行促進効果を高めて、温まり感を有効に増強させることができる。 According to the solid bath salt of the present invention, while using magnesium sulfate hydrate as one component, it prevents the occurrence of sticking and secures good moldability, and is excellent in bath water even after long-term storage. In addition to being able to express solubility, it is possible to further enhance the blood circulation promoting effect and effectively enhance the feeling of warmth.
以下、本発明について詳細に説明する。 Hereinafter, the present invention will be described in detail.
本発明の固形入浴剤は、成分(A)として、フマル酸を35質量%以上含む有機酸を含有する。フマル酸は、有機酸のなかでも特に浴水への溶解性が低いものの、後述する成分(C)の硫酸マグネシウム水和物及び成分(D)の硫酸ナトリウムが特定の合計含有量かつ特定の質量比で共存することとも相まって、予想外にも硫酸マグネシウム水和物が存在するが故の成形性や保存安定性の低下を抑制することができ、長期保存後においても浴水への優れた溶解性を発現することが可能となる。 The solid bath salt of the present invention contains an organic acid containing 35% by mass or more of fumaric acid as the component (A). Although fumaric acid has a particularly low solubility in bath water among organic acids, magnesium sulfate hydrate of component (C) and sodium sulfate of component (D), which will be described later, have a specific total content and a specific mass. Combined with the coexistence of ratio, it is possible to suppress the deterioration of moldability and storage stability due to the unexpected presence of magnesium sulfate hydrate, and excellent dissolution in bath water even after long-term storage. It becomes possible to express sex.
フマル酸の含有量は、炭酸ガス発生量を確保する観点、良好な保存安定性を保持する観点、及び長期保存後においても優れた溶解性を発現させる観点から、成分(A)中に、35質量%以上であって、好ましくは50質量%以上であり、より好ましくは95質量%以上であり、好ましくは100質量%以下である。また、フマル酸の含有量は、成分(A)中に、35質量%以上であって、好ましくは50〜100質量%であり、より好ましくは95〜100質量%であり、さらに好ましくは100質量%である。 The content of fumaric acid is 35 in the component (A) from the viewpoint of ensuring the amount of carbon dioxide generated, maintaining good storage stability, and exhibiting excellent solubility even after long-term storage. It is mass% or more, preferably 50 mass% or more, more preferably 95 mass% or more, and preferably 100 mass% or less. The content of fumaric acid in the component (A) is 35% by mass or more, preferably 50 to 100% by mass, more preferably 95 to 100% by mass, and further preferably 100% by mass. %.
成分(A)には、上記フマル酸のほか、その他の有機酸を含有することもできる。かかるフマル酸以外の有機酸としては、リンゴ酸、酒石酸、クエン酸、マレイン酸、コハク酸、フタル酸、グルタル酸、アジピン酸、安息香酸、サリチル酸、及びシュウ酸等から選ばれる1種又は2種以上が挙げられる。なかでも、保存安定性を確保する観点から、クエン酸、リンゴ酸、及びコハク酸から選ばれる1種又は2種以上が好ましい。 In addition to the fumaric acid described above, the component (A) may also contain other organic acids. Examples of the organic acid other than fumaric acid include one or two selected from malic acid, tartaric acid, citric acid, maleic acid, succinic acid, phthalic acid, glutaric acid, adipic acid, benzoic acid, salicylic acid, oxalic acid and the like. The above can be mentioned. Among them, one or more selected from citric acid, malic acid, and succinic acid are preferable from the viewpoint of ensuring storage stability.
成分(A)の含有量は、炭酸ガス発生量を確保し、後述する成分(C)や成分(D)とも相まって充分に血行促進効果を高め、温まり感の増強及びその持続性を有効に図る観点から、本発明の固形入浴剤中に、好ましくは15質量%以上であり、より好ましくは20質量%以上であり、さらに好ましくは30質量%以上であり、好ましくは70質量%以下であり、より好ましくは60質量%以下であり、さらに好ましくは50質量%以下である。 The content of the component (A) secures the amount of carbon dioxide generated, sufficiently enhances the blood circulation promoting effect in combination with the component (C) and the component (D) described later, and effectively enhances the feeling of warmth and its sustainability. From the viewpoint, in the solid bath salt of the present invention, it is preferably 15% by mass or more, more preferably 20% by mass or more, further preferably 30% by mass or more, and preferably 70% by mass or less. It is more preferably 60% by mass or less, and further preferably 50% by mass or less.
本発明の固形入浴剤は、成分(B)として、炭酸塩を含有する。かかる成分(B)は、本発明の固形入浴剤を浴水に投入したときに、上記成分(A)とともに炭酸ガスを発生させて、血行促進効果をもたらし、良好な温まり感を付与することができる。
成分(B)としては、炭酸水素ナトリウム、炭酸水素カリウム等の炭酸モノアルカリ金属塩、並びに炭酸カルシウム等の二価以上の金属の炭酸塩;炭酸ナトリウム、及び炭酸カリウム等の炭酸ジアルカリ金属塩から選ばれる1種又は2種以上が挙げられる。
The solid bath salt of the present invention contains a carbonate as a component (B). When the solid bath salt of the present invention is put into bath water, the component (B) generates carbon dioxide gas together with the component (A) to bring about a blood circulation promoting effect and give a good feeling of warmth. it can.
The component (B) is selected from monoalkalimetal carbonates such as sodium hydrogencarbonate and potassium hydrogencarbonate, and carbonates of divalent or higher metals such as calcium carbonate; dialkalimetal carbonates such as sodium carbonate and potassium carbonate. One kind or two or more kinds are mentioned.
なかでも、温まり感の増強を有効に図りつつ、良好な成形性、並びに高い保存安定性を確保する観点から、炭酸ジアルカリ金属塩を含むのが好ましく、良好な発泡感を確保する観点から、炭酸ナトリウムを含むのがより好ましい。すなわち炭酸モノアルカリ金属塩、並びに炭酸ジアルカリ金属塩を併用するのが好ましい。かかる炭酸ジアルカリ金属塩の含有量は、良好な成形性、並びに高い保存安定性を確保する観点から、成分(B)中に、好ましくは50質量%以上であり、より好ましくは53質量%以上であり、さらに好ましくは55質量%以上であり、好ましくは100質量%以下であり、より好ましくは90質量%以下であり、さらに好ましくは80質量%以下である。また、炭酸ジアルカリ金属塩の含有量は、成分(B)中に、好ましくは50〜100質量%であり、より好ましくは53〜90質量%であり、さらに好ましくは55〜80質量%である。 Among them, carbonic acid is preferably contained from the viewpoint of ensuring good moldability and high storage stability while effectively enhancing the feeling of warmth, and carbonic acid from the viewpoint of ensuring a good foaming feeling. More preferably, it contains sodium. That is, it is preferable to use a mono-alkali metal carbonate and a di-alkali metal carbonate in combination. The content of the dialkali metal carbonate is preferably 50% by mass or more, more preferably 53% by mass or more in the component (B) from the viewpoint of ensuring good moldability and high storage stability. Yes, more preferably 55% by mass or more, preferably 100% by mass or less, more preferably 90% by mass or less, still more preferably 80% by mass or less. The content of the dialkali metal carbonate in the component (B) is preferably 50 to 100% by mass, more preferably 53 to 90% by mass, and further preferably 55 to 80% by mass.
成分(B)の含有量は、炭酸ガス発生量を確保し、後述する成分(C)や成分(D)とも相まって充分に血行促進効果を高め、温まり感の増強及びその持続性を有効に図る観点から、本発明の固形入浴剤中に、好ましくは15質量%以上であり、より好ましくは20質量%以上であり、さらに好ましくは30質量%以上であり、好ましくは70質量%以下であり、より好ましくは60質量%以下であり、さらに好ましくは50質量%以下である。 The content of the component (B) secures the amount of carbon dioxide generated, sufficiently enhances the blood circulation promoting effect in combination with the component (C) and the component (D) described later, and effectively enhances the feeling of warmth and its sustainability. From the viewpoint, in the solid bath salt of the present invention, it is preferably 15% by mass or more, more preferably 20% by mass or more, further preferably 30% by mass or more, and preferably 70% by mass or less. It is more preferably 60% by mass or less, and further preferably 50% by mass or less.
本発明の固形入浴剤は、成分(C)として、硫酸マグネシウム水和物を含有する。かかる成分(C)は、温まり感を増強させ得る有効成分ではあるものの、固形入浴剤の一成分として用いると、成形性や保存安定性が低下するおそれがあるが、本発明の固形入浴剤では、製造時におけるスティッキング等の発生を有効に防止して良好な成形性を確保することができるとともに、長期保存後においても浴水への充分な溶解性を示すことができる。 The solid bath salt of the present invention contains magnesium sulfate hydrate as the component (C). Although such a component (C) is an active ingredient capable of enhancing a feeling of warmth, when used as one component of a solid bath salt, moldability and storage stability may be deteriorated, but in the solid bath salt of the present invention. , It is possible to effectively prevent the occurrence of sticking and the like during production to ensure good moldability, and it is possible to exhibit sufficient solubility in bath water even after long-term storage.
かかる成分(C)としては、硫酸マグネシウム三水和物、硫酸マグネシウム七水和物が挙げられる。なかでも、良好な成形性や保存安定性を確保する観点、及び取扱い性の観点から、硫酸マグネシウム三水和物が好ましい。 Examples of such a component (C) include magnesium sulfate trihydrate and magnesium sulfate heptahydrate. Of these, magnesium sulfate trihydrate is preferable from the viewpoint of ensuring good moldability and storage stability, and from the viewpoint of handleability.
成分(C)の含有量は、後述する成分(D)やその他の成分とも相まって、温まり感を有効に増強させる観点から、本発明の固形入浴剤中に、好ましくは0.03質量%以上であり、より好ましくは0.1質量%以上であり、さらに好ましくは1質量%以上である。また、成分(C)の含有量は、良好な成形性や保存安定性を確保する観点、及び長期保存後における浴水への良好な溶解性を確保する観点から、本発明の固形入浴剤中に、好ましくは12.5質量%以下であり、より好ましくは10質量%以下であり、さらに好ましくは5質量%以下である。そして、成分(C)の含有量は、本発明の固形入浴剤中に、好ましくは0.03〜12.5質量%であり、より好ましくは0.1〜10質量%であり、さらに好ましくは1〜5質量%である。 The content of the component (C) is preferably 0.03% by mass or more in the solid bath salt of the present invention from the viewpoint of effectively enhancing the feeling of warmth in combination with the component (D) described later and other components. Yes, more preferably 0.1% by mass or more, still more preferably 1% by mass or more. Further, the content of the component (C) is contained in the solid bath salt of the present invention from the viewpoint of ensuring good moldability and storage stability, and from the viewpoint of ensuring good solubility in bath water after long-term storage. In addition, it is preferably 12.5% by mass or less, more preferably 10% by mass or less, and further preferably 5% by mass or less. The content of the component (C) is preferably 0.03 to 12.5% by mass, more preferably 0.1 to 10% by mass, and further preferably 0.1 to 10% by mass in the solid bath salt of the present invention. It is 1 to 5% by mass.
本発明の固形入浴剤は、成分(D)として、硫酸ナトリウムを含有する。かかる成分(D)は、成分(C)による温まり感の増強を促進させる作用を有するとともに、成分(C)の存在による成形性や保存安定性の低下を有効に抑制することができる。 The solid bath salt of the present invention contains sodium sulfate as a component (D). Such a component (D) has an action of promoting the enhancement of the feeling of warmth caused by the component (C), and can effectively suppress a decrease in moldability and storage stability due to the presence of the component (C).
成分(D)の含有量は、成分(C)やその他の成分とも相まって、温まり感を有効に増強させる観点から、本発明の固形入浴剤中に、好ましくは0.03質量%以上であり、より好ましくは0.1質量%以上であり、さらに好ましくは1質量%以上である。また、成分(D)の含有量は、良好な成形性や保存安定性を確保する観点、及び長期保存後における浴水への良好な溶解性を確保する観点から、本発明の固形入浴剤中に、好ましくは19.5質量%以下であり、より好ましくは15質量%以下であり、さらに好ましくは10質量%以下である。そして、成分(C)の含有量は、本発明の固形入浴剤中に、好ましくは0.03〜19.5質量%であり、より好ましくは0.1〜15質量%であり、さらに好ましくは1〜10質量%である。 The content of the component (D) is preferably 0.03% by mass or more in the solid bath salt of the present invention from the viewpoint of effectively enhancing the feeling of warmth in combination with the component (C) and other components. It is more preferably 0.1% by mass or more, and further preferably 1% by mass or more. Further, the content of the component (D) is contained in the solid bath salt of the present invention from the viewpoint of ensuring good moldability and storage stability, and from the viewpoint of ensuring good solubility in bath water after long-term storage. In addition, it is preferably 19.5% by mass or less, more preferably 15% by mass or less, and further preferably 10% by mass or less. The content of the component (C) is preferably 0.03 to 19.5% by mass, more preferably 0.1 to 15% by mass, and further preferably 0.1 to 15% by mass in the solid bath salt of the present invention. It is 1 to 10% by mass.
本発明の固形入浴剤において、成分(C)と成分(D)の合計含有量は、これらの成分が相まって温まり感を有効に増強させ、またそれを持続させる観点から、本発明の固形入浴剤中に、0.1質量%以上であって、好ましくは1質量%以上であり、より好ましくは2質量%以上であり、さらに好ましくは3質量%以上である。また、成分(C)と成分(D)の合計含有量は、良好な成形性や保存安定性を確保する観点、及び長期保存後における浴水への良好な溶解性を確保する観点から、本発明の固形入浴剤中に、25質量%以下であって、好ましくは20質量%以下であり、より好ましくは15質量%以下であり、さらに好ましくは10質量%以下である。そして、成分(C)と成分(D)の合計含有量は、本発明の固形入浴剤中に、0.1質量%以上25質量%以下であって、好ましくは1〜20質量%であり、より好ましくは2〜15質量%であり、さらに好ましくは3〜10質量%である。 In the solid bath salt of the present invention, the total content of the component (C) and the component (D) is the solid bath salt of the present invention from the viewpoint that these components are combined to effectively enhance and maintain the feeling of warmth. Among them, it is 0.1% by mass or more, preferably 1% by mass or more, more preferably 2% by mass or more, and further preferably 3% by mass or more. Further, the total content of the component (C) and the component (D) is determined from the viewpoint of ensuring good moldability and storage stability, and from the viewpoint of ensuring good solubility in bath water after long-term storage. In the solid bath salt of the present invention, it is 25% by mass or less, preferably 20% by mass or less, more preferably 15% by mass or less, and further preferably 10% by mass or less. The total content of the component (C) and the component (D) is 0.1% by mass or more and 25% by mass or less, preferably 1 to 20% by mass, in the solid bath salt of the present invention. It is more preferably 2 to 15% by mass, and even more preferably 3 to 10% by mass.
本発明の固形入浴剤において、成分(C)の含有量と成分(D)の含有量との質量比((C)/(D))は、良好な成形性を確保しつつ、温まり感の増強を図る観点から、0.28以上であって、好ましくは0.29以上であり、より好ましくは0.3以上である。また、成分(C)の含有量と成分(D)の含有量との質量比((C)/(D))は、長期保存後における浴水への良好な溶解性を有効に兼ね備える観点から、2.0以下であって、好ましくは1.0以下であり、より好ましくは0.8以下であり、さらに好ましくは0.5以下である。そして、成分(C)の含有量と成分(D)の含有量との質量比((C)/(D))は、0.28以上2.0以下であって、好ましくは0.29〜1.0であり、より好ましくは0.3〜0.8であり、さらに好ましくは0.3〜0.5である。 In the solid bath salt of the present invention, the mass ratio ((C) / (D)) of the content of the component (C) to the content of the component (D) gives a feeling of warmth while ensuring good moldability. From the viewpoint of enhancing, it is 0.28 or more, preferably 0.29 or more, and more preferably 0.3 or more. Further, the mass ratio ((C) / (D)) of the content of the component (C) to the content of the component (D) is from the viewpoint of effectively combining good solubility in bath water after long-term storage. , 2.0 or less, preferably 1.0 or less, more preferably 0.8 or less, still more preferably 0.5 or less. The mass ratio ((C) / (D)) of the content of the component (C) to the content of the component (D) is 0.28 or more and 2.0 or less, preferably 0.29 to 0.29 to 2.0. It is 1.0, more preferably 0.3 to 0.8, and even more preferably 0.3 to 0.5.
成分(A)と成分(B)の合計含有量と、成分(C)と成分(D)の合計含有量との質量比({(A)+(B)}/{(C)+(D)})は、発生する炭酸ガスによる良好な発泡感を得る観点から、好ましくは3以上であり、より好ましくは4以上であり、さらに好ましくは5以上である。また、成分(A)と成分(B)の合計含有量と、成分(C)と成分(D)の合計含有量との質量比({(A)+(B)}/{(C)+(D)})は、温まり感の増強を有効に図りつつ、長期保存後における浴水への良好な溶解性をも確保する観点から、好ましくは100以下であり、より好ましくは75以下であり、さらに好ましくは50以下である。そして、成分(A)と成分(B)の合計含有量と、成分(C)と成分(D)の合計含有量との質量比({(A)+(B)}/{(C)+(D)})は、好ましくは3〜100であり、より好ましくは4〜75であり、さらに好ましくは5〜50である。 Mass ratio of the total content of component (A) and component (B) to the total content of component (C) and component (D) ({(A) + (B)} / {(C) + (D) )}) Is preferably 3 or more, more preferably 4 or more, still more preferably 5 or more, from the viewpoint of obtaining a good foaming feeling due to the generated carbon dioxide gas. Further, the mass ratio of the total content of the component (A) and the component (B) to the total content of the component (C) and the component (D) ({(A) + (B)} / {(C) + (D)}) is preferably 100 or less, more preferably 75 or less, from the viewpoint of effectively enhancing the feeling of warmth and ensuring good solubility in bath water after long-term storage. , More preferably 50 or less. Then, the mass ratio of the total content of the component (A) and the component (B) to the total content of the component (C) and the component (D) ({(A) + (B)} / {(C) + (D)}) is preferably 3 to 100, more preferably 4 to 75, and even more preferably 5 to 50.
本発明の固形入浴剤は、良好な成形性並びに溶解性を発現させる観点から、さらに水溶性高分子(E)を含有することが好ましい。かかる成分(E)としては、例えば、ポリエチレングリコール、ポリビニルピロリドン、ポリアクリル酸ソーダ、ポリエチレンイミン、ポリビニルアルコール等の合成水溶性高分子;にかわ、ゼラチン、コラーゲンタンパク、カゼイン、アルギン酸ナトリウム、カラギーナン、ファーセレラン、タマリンドガム、ペクチン、アラビアガム、グアーガム、キサンタンガム、トラガントガム、ローカストビーンガム、デキストリン、デキストラン、寒天、澱粉等の天然水溶性高分子;カルボキシメチルセルロース、メチルセルロース、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、酢酸フタル酸セルロース、アルギン酸プロピレングリコールエステル、酸化澱粉、エステル化澱粉、エーテル化澱粉、カチオン澱粉等の半合成水溶性高分子等から選ばれる1種又は2種以上が挙げられる。なかでも、ポリエチレングリコール、及びデキストリンから選ばれる1種又は2種が好ましく、ポリエチレングリコールがより好ましい。 The solid bath salt of the present invention preferably further contains a water-soluble polymer (E) from the viewpoint of exhibiting good moldability and solubility. Examples of such component (E) include synthetic water-soluble polymers such as polyethylene glycol, polyvinylpyrrolidone, sodium polyacrylic acid, polyethyleneimine, and polyvinyl alcohol; starch, gelatin, collagen protein, casein, sodium alginate, carrageenan, and furcereran. Natural water-soluble polymers such as tamarind gum, pectin, arabic gum, guar gum, xanthan gum, tragant gum, locust bean gum, dextrin, dextran, agar, starch; carboxymethyl cellulose, methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, cellulose acetate, One or more selected from semi-synthetic water-soluble polymers such as propylene glycol alginate, oxidized starch, esterified starch, etherified starch, and cationic starch can be mentioned. Among them, one or two selected from polyethylene glycol and dextrin are preferable, and polyethylene glycol is more preferable.
成分(E)の含有量は、良好な成形性並びに溶解性を確保する観点から、本発明の固形入浴剤中に、好ましくは1質量%以上であり、より好ましくは1.5質量%以上であり、さらに好ましくは2質量%以上である。また、成分(E)の含有量は、炭酸ガス発生量を確保する観点から、本発明の固形入浴剤中に、好ましくは25質量%以下であり、より好ましくは20質量%以下であり、さらに好ましくは15質量%以下である。 The content of the component (E) is preferably 1% by mass or more, more preferably 1.5% by mass or more in the solid bath salt of the present invention from the viewpoint of ensuring good moldability and solubility. Yes, more preferably 2% by mass or more. Further, the content of the component (E) is preferably 25% by mass or less, more preferably 20% by mass or less, and further preferably 20% by mass or less in the solid bath salt of the present invention from the viewpoint of ensuring the amount of carbon dioxide gas generated. It is preferably 15% by mass or less.
本発明の固形入浴剤は、油剤を含有してもよい。かかる油剤を含有することにより、成分(A)及び成分(B)により発生する炭酸ガスの泡を微細化して良好な使用感をもたらし、また温まり感の増強を促進することもできる。かかる油剤としては、オクタン酸セチル、イソオクタン酸セチル、乳酸ミリスチル、乳酸セチル、ミリスチン酸イソプロピル、ミリスチン酸ミリスチル、ミリスチン酸イソセチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸イソステアリル、アジピン酸イソプロピル、ステアリン酸ブチル、ステアリン酸イソセチル、イソステアリン酸イソステアリル、イソノナン酸イソトリデシル、オレイン酸デシル、イソステアリン酸コレステロール等の脂肪酸エステル;
トリ(カプリル酸・カプリン酸)グリセリン、トリカプリル酸グリセリル等の脂肪酸トリグリセライド;
大豆油、ヌカ油、ホホバ油、アボガド油、アーモンド油、オリーブ油、カカオ脂、ゴマ油、パーシック油、ヒマシ油、ヤシ油、ミンク油、牛脂、豚脂等の天然油脂、これらの天然油脂を水素添加して得られる硬化油及びミリスチン酸グリセリド、2−エチルヘキサン酸グリセリド等のグリセリド;
流動パラフィン、ワセリン、パラフィン、マイクロクリスタリンワックス、セレシン、スクワラン、スクアレン、ジオクチルシクロヘキサン、ブリスタン等の炭化水素油;
ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘニン酸、オレイン酸、リノール酸、リノレン酸、ラノリン酸、イソステアリン酸等の高級脂肪酸;
ハッカ油、ジャスミン油、ショウ脳油、ヒノキ油、トウヒ油、リュウ油、テレピン油、ケイ皮油、ベルガモット油、ミカン油、ショウブ油、パイン油、ラベンダー油、ベイ油、クローブ油、ヒバ油、バラ油、ユーカリ油、レモン油、タイム油、ペパーミント油、ローズ油、セージ油、メントール、シネオール、オイゲノール、シトラール、シトロネラール、ボルネオール、リナロール、ゲラーオール、カンファー、チモール、スピラントール、ピネン、リモネン、テルペン系化合物等の精油;
シリコーン油等から選ばれる1種又は2種以上が挙げられる。
The solid bath salt of the present invention may contain an oil agent. By containing such an oil agent, the bubbles of carbon dioxide gas generated by the component (A) and the component (B) can be made finer to bring about a good feeling of use, and it is also possible to promote the enhancement of the feeling of warmth. Examples of such oils include cetyl octanoate, cetyl isooctanoate, myristyl lactate, cetyl lactate, isopropyl myristate, myristyl myristate, isocetyl myristate, octyldodecyl myristate, isopropyl palmitate, isostearyl palmitate, isopropyl adipate, stearic acid. Fatty acid esters such as butyl acid acid, isocetyl stearate, isostearyl isostearate, isotridecyl isononanoate, decyl oleate, cholesterol isostearate;
Fatty acid triglyceride such as tri (caprylic acid / capric acid) glycerin and glyceryl tricaprylate;
Natural fats and oils such as soybean oil, nuka oil, jojoba oil, avocado oil, almond oil, olive oil, cacao fat, sesame oil, persic oil, castor oil, coconut oil, mink oil, beef fat, pork fat, and hydrogenated these natural fats and oils. Hardened oil and glycerides such as myristic acid glyceride and 2-ethylhexanoic acid glyceride;
Hydrocarbon oils such as liquid paraffin, petrolatum, paraffin, microcrystalline wax, selecin, squalane, squalene, dioctylcyclohexane, and pristane;
Higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, linoleic acid, linolenic acid, lanolinic acid, isostearic acid;
Hakka oil, jasmine oil, show brain oil, hinoki oil, peppermint oil, ryu oil, terepine oil, coconut skin oil, bergamot oil, orange oil, shove oil, pine oil, lavender oil, bay oil, clove oil, hiba oil, Rose oil, eucalyptus oil, lemon oil, thyme oil, peppermint oil, rose oil, sage oil, menthol, cineole, eugenol, citral, citroneral, borneol, linalol, gellerall, camphor, timole, spirantol, pinen, limonen, terpen Essential oils such as compounds;
One type or two or more types selected from silicone oil and the like can be mentioned.
なかでも、微細な泡を実現し、入浴後における使用感を増強させる観点から、ミリスチン酸イソプロピル、ミリスチン酸ミリスチル、ミリスチン酸イソセチル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸イソステアリル、イソステアリン酸イソステアリル、トリ(カプリル酸・カプリン酸)グリセリン及びトリカプリル酸グリセリルから選ばれる1種又は2種以上が好ましい。 Among them, from the viewpoint of realizing fine bubbles and enhancing the feeling of use after bathing, isopropyl myristate, myristyl myristate, isosetyl myristate, octyldodecyl myristate, isopropyl palmitate, isostearyl palmitate, isostearate isostearate. One or more selected from stearyl, tri (caprylic acid / capric acid) glycerin and glyceryl tricaprylate are preferable.
本発明の固形入浴剤には、その他上記成分以外の成分として、通常入浴剤に用いられる成分を適宜含有させてもよい。かかる成分としては、例えば、ショ糖脂肪酸エステルやポリエチレングリコール脂肪酸エステル、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油等のノニオン界面活性剤、及びその他の界面活性剤;塩化カリウム、塩化ナトリウム、硝酸カリウム、硝酸ナトリウム、ポリリン酸ナトリウム、塩化アンモニウム、硫酸鉄、リン酸ナトリウム、チオ硫酸ナトリウム等の、上記成分以外の無機塩;ケイ酸カルシウム、ブドウ糖等の賦形剤;崩壊助剤;生薬等の薬効成分;色素;香料等が挙げられる。 The solid bath salt of the present invention may appropriately contain a component usually used for a bath salt as a component other than the above-mentioned components. Such components include, for example, nonionic surfactants such as sucrose fatty acid ester, polyethylene glycol fatty acid ester, polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, and other surfactants; potassium chloride, sodium chloride, potassium nitrate. , Sodium nitrate, sodium polyphosphate, ammonium chloride, iron sulfate, sodium phosphate, sodium thiosulfate, and other inorganic salts other than the above components; excipients such as calcium silicate and glucose; disintegration aids; medicinal properties of crude drugs, etc. Ingredients; pigments; fragrances and the like.
本発明の固形入浴剤は、プレス打錠機やブリケットマシーンを用いた圧縮成形法や、押出造粒等の圧縮造粒方法等の常法に従って製造することができ、その形態はブリケット錠、錠剤、粉末、顆粒、粒状等のいずれであってもよい。また、成分の一部を予め造粒あるいは成型してその余の成分と混合した後に成形した形態であってもよい。なかでも、より長期保存後においても高い溶解性を確保する観点から、錠剤の形態であるのが好ましい。 The solid bath salt of the present invention can be produced according to a conventional method such as a compression molding method using a press tableting machine or a briquette machine, or a compression granulation method such as extrusion granulation, and the form thereof is a briquette tablet or tablet. , Powder, granules, granules and the like. Further, a part of the component may be granulated or molded in advance, mixed with the remaining component, and then molded. Among them, the tablet form is preferable from the viewpoint of ensuring high solubility even after longer-term storage.
以下、本発明について、実施例に基づき具体的に説明する。なお、表中に特に示さない限り、各成分の含有量は質量%を示す。 Hereinafter, the present invention will be specifically described based on examples. Unless otherwise specified in the table, the content of each component indicates mass%.
[実施例1〜8、比較例1〜5]
表1に示す処方にしたがって、各入浴剤を得た。
なお、形態が錠剤のものについては、各成分を混合して得られた粉末を用い、ロータリー打錠機にて、質量39〜41gで100錠連続圧縮成形した後、成形性(スティッキングの有無)の評価を行った。また、形態がブリケットのものについては、各成分を混合して得られた粉末を用い、ブリケッター(新東工業製:ラボ用ブリケッタBGS−0L、φ10mm)に上記組成物10kgを投入して連続圧縮成形した後、成形性(スティッキング)の評価を行った。
得られた入浴剤を用い、以下に示す方法にしたがって各評価を行った。結果を表1に示す。
[Examples 1 to 8 and Comparative Examples 1 to 5]
Each bath salt was obtained according to the formulation shown in Table 1.
For tablets in the form of tablets, 100 tablets are continuously compression-molded with a rotary tableting machine using a powder obtained by mixing each component with a mass of 39 to 41 g, and then moldability (presence or absence of sticking). Was evaluated. For briquettes in the form, 10 kg of the above composition is put into a briquette (manufactured by Shinto Kogyo: laboratory briquette BGS-0L, φ10 mm) using powder obtained by mixing each component and continuously compressed. After molding, the moldability (sticking) was evaluated.
Using the obtained bath salt, each evaluation was performed according to the method shown below. The results are shown in Table 1.
《成形性(スティッキングの有無)》
入浴剤の製造時における圧縮工程の際、スティッキングの有無について、下記基準にしたがって目視により評価した。
A:杵又はロールに一切付着しなかった
B:杵又はロールの表面にうっすらと付着があるが、剤表面は滑らかであった
C:杵な又はロールの表面に付着があり、剤表面に凹凸が見られた
D:杵又はロールの表面に明らかな付着があり、剤形状に影響を及ぼしていた
<< Moldability (presence or absence of sticking) >>
During the compression process during the production of bath salts, the presence or absence of sticking was visually evaluated according to the following criteria.
A: No adhesion to the pestle or roll B: Slight adhesion to the surface of the pestle or roll, but the surface of the agent was smooth C: Adhesion to the surface of the pestle or roll, unevenness on the surface of the agent D: There was a clear adhesion on the surface of the pestle or roll, which affected the shape of the agent.
《入浴中における温まり感》
浴槽に40℃150Lの浴水を入れ、得られた入浴剤40gを投入して完全に溶解させた後、速やかにパネラーを10分間入浴させ、かかる入浴中における温まり感について、6段階で点数評価し(1点から6点まで、6点が最高評価)、パネラー10名の平均値を算出した後、さらに下記基準にしたがって評価結果とした。
〔評価基準〕
6点:非常に温まりを感じた
5点:温まりを感じた
4点:やや温まりを感じた
3点:さら湯と同等
2点:あまり温まりを感じなかった
1点:温まりを感じなかった
〔判定基準〕
AA:5点以上
A:4.5点以上5点未満
B:4点以上4.5点未満
C:3.5点以上4点未満
D:3.5点未満
<< Warmth while taking a bath >>
After putting 150 L of bath water at 40 ° C into the bathtub and adding 40 g of the obtained bath salt to completely dissolve it, the panelists were immediately bathed for 10 minutes, and the feeling of warmth during the bath was evaluated on a 6-point scale. (1 to 6 points, 6 points is the highest evaluation), and after calculating the average value of 10 panelists, the evaluation result was further determined according to the following criteria.
〔Evaluation criteria〕
6 points: I felt very warm 5 points: I felt warm 4 points: I felt a little warm 3 points: Equivalent to Sarayu 2 points: I did not feel much warm 1 point: I did not feel warm [Judgment criteria] ]
AA: 5 points or more A: 4.5 points or more and less than 5 points B: 4 points or more and less than 4.5 points C: 3.5 points or more and less than 4 points D: less than 3.5 points
《発泡感》
上記の入浴中における温まり感の評価において、入浴剤を浴水に溶解させている際に得られた発泡感の感触について、6段階で点数評価し(1点から6点まで、6点が最高評価)、パネラー10名の平均値を算出した後、さらに下記基準にしたがって評価結果とした。
〔評価基準〕
6点:強く発泡を感じた
5点:発泡を感じた
4点:やや発泡を感じた
3点:どちらともいえない
2点:あまり発泡を感じなかった
1点:発泡を感じなかった
〔判定基準〕
AA:5点以上
A:4.5点以上5点未満
B:4点以上4.5点未満
C:3.5点以上4点未満
D:3.5点未満
《Foam feeling》
In the above evaluation of the feeling of warmth during bathing, the feeling of foaming obtained when the bath salt was dissolved in bath water was evaluated on a 6-point scale (6 points from 1 point to 6 points is the highest). Evaluation), after calculating the average value of 10 panelists, the evaluation result was further calculated according to the following criteria.
〔Evaluation criteria〕
6 points: I felt strong foaming 5 points: I felt foaming 4 points: I felt some foaming 3 points: I can't say either 2 points: I didn't feel much foaming 1 point: I didn't feel foaming [Judgment criteria] ]
AA: 5 points or more A: 4.5 points or more and less than 5 points B: 4 points or more and less than 4.5 points C: 3.5 points or more and less than 4 points D: less than 3.5 points
《入浴後における温まり感の持続性》
上記の入浴中における温まり感の評価において、10分間入浴した後、浴後30分間経過した時点における足先の温度感覚について、9段階で点数評価し(1点から9点まで、9点が最高評価)、パネラー10名の平均値を算出した後、さらに下記基準にしたがって評価結果とした。
〔評価基準〕
9点:非常に温かい
8点:とても温かい
7点:温かい
6点:やや温かい
5点:どちらでもない
4点:やや冷たい
3点:冷たい
2点:とても冷たい
1点:非常に冷たい
〔判定基準〕
AA:8点以上
A:7点以上8点未満
B:6点以上7点未満
C:5点以上6点未満
D:5点未満
《Sustainability of warmth after bathing》
In the above evaluation of the feeling of warmth during bathing, the temperature sensation of the toes at the time when 30 minutes have passed after bathing for 10 minutes was evaluated on a 9-point scale (9 points from 1 point to 9 points is the highest evaluation). ), After calculating the average value of 10 panelists, the evaluation result was further calculated according to the following criteria.
〔Evaluation criteria〕
9 points: Very warm 8 points: Very warm 7 points: Warm 6 points: Slightly warm 5 points: Neither 4 points: Slightly cold 3 points: Cold 2 points: Very cold 1 point: Very cold [Criteria]
AA: 8 points or more A: 7 points or more and less than 8 points B: 6 points or more and less than 7 points C: 5 points or more and less than 6 points D: 5 points or less
《長期保存後における浴水への溶解性》
得られた製造直後の入浴剤を40℃で6ヶ月間保存した後、40℃150Lの浴水に投入し、入浴剤の溶解具合について、下記式(1)に基づき長期保存後の浴水への溶解時間の延伸度合(X)を算出した後、得られたXの値を指標として下記基準にしたい評価した。
(長期保存後の浴水への溶解時間の延伸度合(X))
={長期保存後の溶解時間/初期の溶解時間}×100 式(1)
〔判定基準〕
AA: X<122
A : 122≦X<125
B : 125≦X<130
C : 130≦X<140
D : 140≦X
《Solubility in bath water after long-term storage》
The obtained bath salt immediately after production is stored at 40 ° C. for 6 months, then put into bath water at 40 ° C. and 150 L, and the degree of dissolution of the bath salt is changed to the bath water after long-term storage based on the following formula (1). After calculating the degree of elongation (X) of the dissolution time of the above, the evaluation was made using the obtained value of X as an index to use as the following criteria.
(Degree of extension of dissolution time in bath water after long-term storage (X))
= {Dissolution time after long-term storage / Initial dissolution time} × 100 Equation (1)
[Criteria]
AA: X <122
A: 122 ≤ X <125
B: 125 ≤ X <130
C: 130 ≤ X <140
D: 140 ≤ X
Claims (7)
(A)フマル酸を35質量%以上含む有機酸、
(B)炭酸塩、
(C)硫酸マグネシウム水和物、及び
(D)硫酸ナトリウム
を含有し、成分(C)と成分(D)の合計含有量が0.1質量%以上25質量%以下であり、かつ成分(C)の含有量と成分(D)の含有量との質量比((C)/(D))が0.28以上2.0以下である固形入浴剤。 The following components (A), (B), (C), and (D):
(A) An organic acid containing 35% by mass or more of fumaric acid,
(B) Carbonate,
It contains (C) magnesium sulfate hydrate and (D) sodium sulfate, and the total content of the component (C) and the component (D) is 0.1% by mass or more and 25% by mass or less, and the component (C). ) To the mass ratio ((C) / (D)) of the content of the component (D) is 0.28 or more and 2.0 or less.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017028602A JP6829620B2 (en) | 2017-02-20 | 2017-02-20 | Solid bath salt |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017028602A JP6829620B2 (en) | 2017-02-20 | 2017-02-20 | Solid bath salt |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018135271A JP2018135271A (en) | 2018-08-30 |
JP6829620B2 true JP6829620B2 (en) | 2021-02-10 |
Family
ID=63366531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017028602A Active JP6829620B2 (en) | 2017-02-20 | 2017-02-20 | Solid bath salt |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6829620B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7217167B2 (en) * | 2019-02-20 | 2023-02-02 | 花王株式会社 | Solid bath agent |
-
2017
- 2017-02-20 JP JP2017028602A patent/JP6829620B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2018135271A (en) | 2018-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5727214B2 (en) | Granular bath agent composition | |
JP7217167B2 (en) | Solid bath agent | |
JP6829620B2 (en) | Solid bath salt | |
JP2016113402A (en) | Bath agent composition | |
JP6629652B2 (en) | Effervescent tablet type bath composition | |
JP5690494B2 (en) | Solid bath composition | |
JP5670660B2 (en) | Bath agent composition | |
JP7335758B2 (en) | Effervescent solid bath agent | |
JP6881928B2 (en) | Effervescent tablet bath composition | |
JP6194184B2 (en) | Bath agent composition | |
JP6320017B2 (en) | Bath agent composition | |
JP2014043410A (en) | Briquette-type bathing agent | |
JP5727193B2 (en) | Compression bath agent | |
JP6617052B2 (en) | Carbon dioxide foaming bath composition | |
JP5918992B2 (en) | Bath agent composition | |
JP6617064B2 (en) | Bath agent composition | |
JP2005314298A (en) | Dropsy-ameliorating agent | |
JP2019131620A (en) | Bathing method using bath agent composition | |
JP6411779B2 (en) | Bath agent composition | |
JP4348208B2 (en) | Compression mold bath agent | |
JP7368830B2 (en) | foaming bath salts | |
JP7042106B2 (en) | Effervescent bath composition | |
JP5945133B2 (en) | Bath agent composition | |
JPH03112922A (en) | Foamable bathing agent for inhibiting floating of fumaric acid | |
JP6209323B2 (en) | Effervescent compression formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191211 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200819 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200901 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201029 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210105 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210122 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 6829620 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |